DEHYDROGENASE CRYSTALS AS CATALYSTS IN ORGANIC SYNTHESIS

Information

  • Research Project
  • 2190496
  • ApplicationId
    2190496
  • Core Project Number
    R43GM051781
  • Full Project Number
    1R43GM051781-01
  • Serial Number
    51781
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/15/1994 - 29 years ago
  • Project End Date
    3/14/1995 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    9/15/1994 - 29 years ago
  • Budget End Date
    3/14/1995 - 29 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/13/1994 - 29 years ago

DEHYDROGENASE CRYSTALS AS CATALYSTS IN ORGANIC SYNTHESIS

DESCRIPTION: (Adapted from the applicant's abstract) Enzyme microcrystals (less than 100 um) grown from aqueous solution and cross- linked with a bifunctional agent such as glutaraldehyde exhibit remarkable characteristics that are superior to both soluble and conventionally immobilized enzymes. Such cross-linked enzyme crystals (CLECs) remain active in environments that are otherwise incompatible with enzyme function, including prolonged exposure to high temperatures, extremes of pH, near-anhydrous organic solvents and aqueous-organic solvent mixtures. CLECs are also remarkably stable against autolysis and exogenous protease degradation. This unique set of properties makes CLECs extremely useful in organic synthesis in general and in the synthesis of optically pure compounds in particular. The authors have demonstrated the synthetic utility of CLECs in the synthesis of aspartame, catalyzed by thermolysin and in the synthesis of optically pure compounds, catalyzed by lipase from Candida rugosa. In this Phase I study, CLECs of a cofactor-dependent enzyme alcohol dehydrogenase (ADH) from two different sources will be investigated to demonstrate the feasibility of using CLECs of cofactor-dependent enzymes for practical stereoselective synthesis. ADH was chosen because it is one of the most studied, as well as useful and versatile cofactor-dependent enzymes for stereoselective organic synthesis.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    ALTUS PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021394807
  • Organization District
    UNITED STATES